Goldman Sachs analyst maintained a Buy rating on Argenx Se today and set a price target of $916.00. The company’s shares closed yesterday at $767.33.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Argenx Se with a $842.25 average price target, implying a 9.76% upside from current levels. In a report released yesterday, Morgan Stanley also maintained a Buy rating on the stock with a $1,040.00 price target.
ARGX market cap is currently $43.91B and has a P/E ratio of 34.65.
Read More on ARGX:
Disclaimer & DisclosureReport an Issue
- Argenx price target raised to $1,040 from $766 at Morgan Stanley
- Vor Bio appoints Khan as Chief Medical Affairs Officer
- Argenx price target raised to $882 from $797 at Stifel
- Argenx Completes Phase 1 Study on ARGX-109: Key Insights for Investors
- Argenx’s Strategic Diversification and Promising Pipeline Highlighted by Buy Rating
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
/Semiconductor%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/An%20image%20of%20a%20Tesla%20humanoid%20robot%20in%20front%20of%20the%20company%20logo%20Around%20the%20World%20Photos%20via%20Shutterstock.jpg)
